Topovale
Topovale (ARC 111) is a topoisomerase I inhbitor. Topovale is an antitumor agent, and shows low nM cytotoxicity against a panel of cancer cells. Topovale induces reversible topoisomerase I (TOP1) cleavage complexes in tumor cells[1].
Product Specifications
CAS Number
500214-53-9
Product Name Alternative
ARC 111
UNSPSC
12352005
Target
Topoisomerase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/topovale.html
Purity
99.94
Solubility
DMSO : 4.03 mg/mL (ultrasonic; adjust pH to 2 with TFA)
Smiles
COC1=C(C=C(C2=C1)C(N(C3=C2C=NC4=C3C=C5OCOC5=C4)CCN(C)C)=O)OC
Molecular Formula
C23H23N3O5
Molecular Weight
421.45
References & Citations
[1]Li TK, et al. Characterization of ARC-111 as a novel topoisomerase I-targeting anticancer drug. Cancer Res. 2003 Dec 1;63 (23) :8400-7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Topo I
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PAX5 / BSAP (Early B-Cell Marker) (PAX5/3735), CF568 conjugate, 0.1mg/mL
